Differential expression of isomorphic HLA-DRβ genes is not a sole function of transcription

Human Immunology

Volumn 50, Issue 2, 1996, Pages 111-120

  Leen, Mathijs P J M ^a   Gorski, Jack ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENETICS; PRIORITY JOURNAL; RNA ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0030272635     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00154-1     Document Type: Article

References (37)

1. 1. Marrack P, Kappler J: The T cell receptor. Science 238: 1073-1078, 1987.
2. 2. Matis LA, Glimcher LH, Paul WE, Schwartz RH: Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci USA 80: 6019-6023, 1983.
3. 3. Berdoz J, Gorski J, Termijtelen A-M, Dayer J-M, Irlé C, Schendel D, Mach B: Constitutive and induced expression of the individual HLA-DRβ and a chain loci in different cell types. J Immunol 139:1336-1341, 1987.
4. 4. Moses H, Panek RB, Benveniste EN, Ting JP-Y: Usage of primary cells to delineate IFN-γ-response DNA elements in the HLA-DRA promoter and to identify a novel IFN-γ-enhanced nuclear factor. J Immunol 148:3643-3651, 1992.
5. 5. Leën MPJM, Ogutu ERL, Gorski J: Structural and functional analysis of HLA-DRβ-promoter polymorphism and isomorphism. Hum Immunol 41:112-120, 1994.
6. 6. Louis P, Eliaou J-F, Kerlan-Candon S, Pinet V, Vincent R, Clot J: Polymorphism in the regulatory region of HLA-DRβ genes correlating with haplotype evolution. Immunogenetics 38:21-26, 1993.
7. 7. Long EO, Wake CT, Gorski J, Mach B: Complete sequence of an HLA-DRβ chain deduced from a cDNA clone and identified of multiple non-allelic DRβ chain genes. EMBO J 2:389-394, 1983.
8. 8. Reith W, Satola S, Herrero-Sanchez C, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B: Congenital immunodeficiency with a regulatory defect in MHC Class II gene expression lacks a specific HLA-DR promoter binding protein, RFX. Cell 53:897-906, 1988.
9. 9. Reith W, Barras E, Satola S, Kobr M, Reinhart D, Herrero-Sanchez C, Mach B: Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci USA 86:4200-4204, 1989.
10. 10. Kobr M, Reith W, Herrero-Sanchez C, Mach B: Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol 10:965-971, 1990.
11. 11. Stunz LL, Karr RW, Anderson RA: HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level. J Immunol 143:3081-3086, 1989.
12. 12. Emery P, Mach B, Reith W: The differential level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum Immunol 38:137-147, 1993.
13. 13. Singhal DP, Qiu X: Polymorphism in the upstream regulatory region and level of expression of HLA-DRβ genes. Mol Immunol 31:1117-1120, 1994.
14. 14. Louis P, Vincent R, Cavadore P, Clot J, Eliaou J-F: Differential transcriptional activities of HLA-DR genes in the various haplotypes. J Immunol 153:5059-5067, 1994.
15. 15. Andersen LC, Beaty JS, Nettles JW, Seyfried CE, Nepom GT, Nepom BS: Allelic polymorphism in transcriptional regulatory regions of HLA-DQβ genes. J Exp Med 173: 181-192, 1991.
16. 16. Shewey LM, Beaty JS, Andersen LC, and Nepom GT: Differential expression of related HLA class II DQβ genes caused by nucleotide variation in transcriptional regulatory elements. J Immunol 148:1265-1273, 1992.
17. 17. Voliva CF, Tsang S, Peterlin BM: Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes. Proc Natl Acad Sci USA 90: 3408-3412, 1993.
18. 18. Dedrick RL, Jones PP: Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol 10:593-604, 1990.
19. 19. Tsang SY, Nakanishi M, Peterlin BM: Mutational analysis of the DRA promoter: Cis-acting sequences and transacting factors. Mol Cell Biol 10:711-719, 1990.
20. + cell types. J Immunol 146:1361-1367, 1991.
21. 21. Kouskoff V, Mantovani RM, Candéias SM, Dorn A, Staub A, Lisowska-Grospierre B, Griscelli C, Benoist CO, Mathis DJ: NF-X, a transcription factor implicated in MHC class II gene regulation. J Immunol 146:3197-3204, 1991.
22. 22. Sugawara M, Ponath PD, Shin J, Yang Z, Strominger J: Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression. Proc Natl Acad Sci USA 88:10347-10351, 1991.
23. 23. Sloan JH, Hasegawa SL, Boss JM: Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J Immunol 148: 2591-2599, 1992.
24. 24. Sutton VR, Kienzle BK, Knowles RW: An altered splice site is found in the DRB4 gene that is not expressed in HLA-DR7, Dw11 individuals. Immunogenet 29:317-322, 1989.
25. 25. MacGregor GR, Caskey CT: Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res 17:2365, 1989.
26. 26. Glisin V, Crkvenjakov R, Byus C: Ribonucleic acid isolated by CsCl centrifugation. Biochem 13:2633-2637, 1974.
27. 27. Perfetto C, Zacheis M, Mcdaid D, Meador III JW, Schwartz BD: Polymorphism in the promoter region of HLA-DRB genes. Hum Immunol 36:27-33, 1993.
28. 28. Duh J-L, Zhu H, Shertzer HG, Nebert DW, Puga A: The Y-box motif mediates redox-dependent transcriptional activation in mouse cells. J Biol Chem 270:30499-30507, 1995.
29. 29. Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD: Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 85:7322-7326, 1988.
30. 30. Rollini P, Mach B, Gorski J: Characterization of an HLA-DR beta pseudogene in the DRw52 supertypic group. Immunogenetics 25:336-342, 1987.
31. 31. Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B: Complexity of the supertypic HLA DRw53 specificity: Two distinct epitopes differentially expressed on one or all of the DRβ-chains depending on the HLA-DR allotype. J Immunol 137:2618-2626, 1986.
32. 32. Gregersen PK, Moriuchi T, Karr R W, Obata F, Moriuchi J, Maccari J, Goldberg D, Winchester RJ, Silver J: Polymorphism of HLA-DRβ chains in DR4, -7, -9 haplotypes: Implications for the mechanisms of allelic variation. Proc Natl Acad Sci USA 83:9149-9153, 1986.
33. 33. Gyllensten U, Sundvall M, Ezcurra I, Erlich H: Genetic diversity at class II DRB loci of the primate MHC. J Immunol 146:4368-4376, 1991.
34. 34. Kenter M, Otting N, Anholts J, Jonker M, Schipper R, Bontrop RE: MHC-DRB diversity of the chimpanzee (Pan troglodytes). Immunogenetics 37:1-11, 1992.
35. 35. Slierendregt BL, van Noort JT, Bakas RM, Otting N, Jonker M, Bontrop RE: Evolutionary stability of transspecies Major Histocompatibility Complex class II DRB lineages in humans and Rhesus monkeys. Hum Immunol 35:29-39, 1992.
36. 36. Kinouchi R, Kobayasi H, Sato K, Kimura S, Katagiri M: Peptide motifs of HLA-DR4/DR53 (DRB1*0405/ DRB4*0101) molecules. Immunogenetics 40:376-378, 1994.
37. 37. Futaki G, Kobayashi H, Sato K, Taneichi M, Katagiri M: Naturally processed HLA-DR9/DR53 (DRB1*0901/ DRB4*0101)-bound peptides. Immunogenetics 42:299-301, 1995.